Job Opportunities API

For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.  Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Key Account Manager is responsible for developing and executing institutional strategies to increase disease awareness, enhance system-level partnerships, and establish sustainable screening and identification pathways for hypercortisolism across targeted integrated delivery networks (IDNs), academic medical centers, and large healthcare systems. KAMs engage a broad range of clinical and operational stakeholders including endocrinologists, diabetologists, cardiologists, neurosurgeons, endocrine surgeons, interventional radiologists, informatics leaders, quality teams, care coordination, population health, and senior system leadership. Although the KAM role is part of Corcept’s Commercial organization, the role is not focused on branded promotion. Performance metrics, business objectives, and compensation are not tied to Korlym promotion or prescribing behavior KAMs are not encouraged or incentivized to detail Korlym, promote prescribing, or discuss tactics intended to influence individual treatment decisions Instead, the KAM role centers on disease education, institutional workflow alignment, and system change—not selling KAMs may provide accurate, balanced information about the FDA-approved use of Korlym when necessary to support system-level initiatives such as pathway development or EMR decision-support tools, while maintaining clear, compliant role boundaries. The KAM works in deep collaboration with Clinical Specialists (CSs), Thought Leader Liaisons (TLLs), Medical Science Liaisons (MSLs), Market Access, Medical Affairs, Marketing, and Field Medical to ensure aligned, coordinated institutional strategy. Responsibilities: Execute Target Health System Strategy Assess, map, and prioritize complex health system structures, workflows, and stakeholder networks Build and maintain ongoing relationships with clinical, operational, administrative, and population health leaders Establish consistent engagement cadence and long-term partnership plans for targeted institutions Coordinate closely with cross-functional partners to ensure unified system execution Accelerate System-Wide Disease Awareness  Conduct educational engagements with departments involved in screening, diagnosing, and managing complex metabolic diseases Support system grand rounds, medical society events, internal conferences, and departmental education Collaborate with TLLs and CSs to ensure accurate, cohesive dissemination of disease-state understanding across institutions Drive Development of Hypercortisolism Identification Pathways Identify key institutional stakeholders across informatics, quality, clinical operations, and specialty care to develop or enhance: Screening pathways EMR flags and clinical decision-support tools Order sets Referral workflows Multidisciplinary care pathways Facilitate cross-department alignment to ensure operational feasibility and clinical adoption Reinforce pathway use through ongoing education and system-wide implementation support Korlym Education (when appropriate) Provide accurate, balanced information on the FDA-approved use of Korlym to support system-level discussions such as workflow design or pathway planning Maintain